Come up with a name for your new list and we'll add to it:
Eureka Therapeutics raised a round of funding on July 31, 2007. Investors include
Acorn Campus Ventures.
Eureka Therapeutics is focused on the discovery of fully-human antibody drugs for the treatment of cancer. Utilizing its antibody drug discovery and engineering technologies, Eureka is advancing safe …